GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GlaxoSmithKline (GSK) has announced the purchase of 243,000 of its own ordinary shares ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

DiamondRock Hospitality Company (the "Company") today announced it will redeem all 4,760,000 outstanding shares of its 8.250% Series A Cumulative Redeemable Preferred Stock ("Series A Preferred Stock" ...

Apple became the first $1 trillion company on U.S. public markets in 2018. Six of the eight companies to follow in Apple’s ...

Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more ...

The upcoming shareholder vote represents the last major obstacle before the deal receives full formal approval. The meeting's primary agenda item centers on authorizing the transaction structure that ...

The CDC updates its stance on vaccines and autism, acknowledging ongoing debate and new evidence. Read more here.

Psyence Biomedical Ltd. ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced it ...

Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management, as it targets up to 10% revenue ...

Sportradar Group AG (NASDAQ:SRAD) stock fell 5.9% after being identified as a short target in a report from The Bear Cave. The Switzerland-based sports technology company, which specializes in ...

Icelandic biosimilars company Alvotech and privately-held UK firm Advanz Pharma today announced that the European Commission ...